Nemaura Medical Inc. (NMRD) is a Medical/Dental Instruments company listed on NASDAQ. There were no new wire items for NMRD in the last 30 days. The most recent was published Sep 26, 2024.
Latest news
25 items- SECNemaura Medical Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Nemaura Medical Inc. (0001602078) (Filer)
- SECSEC Form DEF 14C filed by Nemaura Medical Inc.DEF 14C - Nemaura Medical Inc. (0001602078) (Filer)
- SECSEC Form NT 10-K filed by Nemaura Medical Inc.NT 10-K - Nemaura Medical Inc. (0001602078) (Filer)
- SECNemaura Medical Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Nemaura Medical Inc. (0001602078) (Filer)
- SECNemaura Medical Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Nemaura Medical Inc. (0001602078) (Filer)
- SECSEC Form PRE 14C filed by Nemaura Medical Inc.PRE 14C - Nemaura Medical Inc. (0001602078) (Filer)
- PRCRAIG D. LINDER SELECTED TO 2024 TOP 50 LAWYERS IN AMERICAWEST PALM BEACH, Fla., April 11, 2024 /PRNewswire/ -- Anthony, Linder & Cacomanolis, PLLC is proud to announce that Partner Craig D. Linder has been selected to the 2024 Top 50 Lawyers in America list for securities law. This prestigious accolade is part of the 10th annual list honoring a select group of 50 lawyers who have demonstrated outstanding leadership and success within the securities law community in the Americas. America's Top 50 Lawyers identifies and highlights the accomplishments of the nation's most distinguished and skilled attorneys in all fields of practice of law. Only 50 lawyers in each state will receive this honor and be selected for this esteemed membership. This hon
- SECNemaura Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits8-K - Nemaura Medical Inc. (0001602078) (Filer)
- SECSEC Form 25-NSE filed by Nemaura Medical Inc.25-NSE - Nemaura Medical Inc. (0001602078) (Subject)
- SECNemaura Medical Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Nemaura Medical Inc. (0001602078) (Filer)
- 13D/GSEC Form SC 13G filed by Nemaura Medical Inc.SC 13G - Nemaura Medical Inc. (0001602078) (Subject)
- SECSEC Form 10-Q filed by Nemaura Medical Inc.10-Q - Nemaura Medical Inc. (0001602078) (Filer)
- SECSEC Form DEFA14A filed by Nemaura Medical Inc.DEFA14A - Nemaura Medical Inc. (0001602078) (Filer)
- SECSEC Form DEF 14A filed by Nemaura Medical Inc.DEF 14A - Nemaura Medical Inc. (0001602078) (Filer)
- NEWSAlzamend Neuro And 3 Other Stocks Under $3 Insiders Are Buying$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying The Dow Jones index closed lower by over 150 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Fortress Biotech The Trade: Fortress Biotech, Inc. (NASDAQ:FBIO) President, CEO and Chairman MD Lindsay Rosenwald acquired a total of 50,000 shares
- INSIDERGhadar-Ghadr Arash bought $14,000 worth of shares (100,000 units at $0.14) (SEC Form 4)4 - Nemaura Medical Inc. (0001602078) (Issuer)
- INSIDERSEC Form 3 filed by new insider Ghadar-Ghadr Arash3 - Nemaura Medical Inc. (0001602078) (Issuer)
- NEWS12 Health Care Stocks Moving In Thursday's After-Market SessionGainers Dermata Therapeutics (NASDAQ:DRMA) stock increased by 113.1% to $1.3 during Thursday's after-market session. The market value of their outstanding shares is at $4.6 million. Intelligent Bio Solutions (NASDAQ:INBS) shares increased by 19.17% to $0.36. The market value of their outstanding shares is at $3.1 million. Exagen (NASDAQ:XGN) shares increased by 15.33% to $2.18. The market value of their outstanding shares is at $37.1 million. Nemaura Medical (NASDAQ:NMRD) shares increased by 12.53% to $0.12. The market value of their outstanding shares is at $3.4 million. Inspire Veterinary (NASDAQ:IVP) shares increased by 9.85% to $0.38. The market value of their outstanding shares is
- NEWSWhy Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionShares of Mobileye Global Inc. (NASDAQ:MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance. For the fourth quarter, the company expects revenue of $634 million-$638 million (vs. $636.39 million) and adjusted operating income of $241 million-$247 million. The company's previous implied guidance was $623 million-$648 million in revenue. Wolfe Research analyst Shreyas Patil downgraded Mobileye Global from Outperform to Peer Perform. Mobileye Global shares dipped 23.5% to $30.37 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Minim, Inc. (NASDAQ:MINM) shares jumped 170.2% t
- NEWS12 Health Care Stocks Moving In Wednesday's After-Market SessionGainers Portage Biotech (NASDAQ:PRTG) shares moved upwards by 20.6% to $1.7 during Wednesday's after-market session. The company's market cap stands at $33.6 million. BIMI Intl Medical (NASDAQ:BIMI) stock rose 9.62% to $2.05. The market value of their outstanding shares is at $23.7 million. Molecular Partners (NASDAQ:MOLN) shares increased by 9.6% to $5.48. The company's market cap stands at $180.0 million. Nemaura Medical (NASDAQ:NMRD) shares rose 9.28% to $0.14. The market value of their outstanding shares is at $4.0 million. Bright Green (NASDAQ:BGXX) stock rose 8.62% to $0.3. The company's market cap stands at $55.5 million. Celularity (NASDAQ:CELU) shares rose 6.04% to $0.3. The m
- SECNemaura Medical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Nemaura Medical Inc. (0001602078) (Filer)
- NEWSNasdaq Down Over 100 Points; Sidus Space Shares Spike HigherU.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Wednesday. The Dow traded down 0.52% to 37,518.35 while the NASDAQ fell 0.98% to 14,621.38. The S&P 500 also fell, dropping, 0.61% to 4,713.82. Check This Out: How To Earn $500 A Month From Apple Stock Following Tuesday's Slide Leading and Lagging Sectors Energy shares rose by 0.8% on Wednesday. In trading on Wednesday, real estate shares fell by 1.8%. Top Headline The number of job openings fell by 62,000 from the prior month to 8.790 million in November, compared to market estimates of 8.85 million. Equities Trading UP Sidus Space, Inc. (NASDAQ:SIDU) s
- NEWSWhy SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionShares of SoFi Technologies, Inc. (NASDAQ:SOFI) fell sharply during Wednesday’s session after Keefe, Bruyette & Woods downgraded rating on the stock. Keefe, Bruyette & Woods analyst Michael Perito downgraded SoFi from a Market Perform rating to an Underperform rating and lowered the price target from $7.50 to $6.50, citing recent outperformance and a change in the analyst's model. SoFi Technologies shares dipped 12.8% to $8.41 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers NexImmune, Inc. (NASDAQ:NEXI) shares rose 150.8% to $6.14 after gaining over 6% on Tuesday. Trinity Place Holdings Inc. (NYSE:TPHS) rose gained 62.6% to $0.1857. The company re
- NEWS12 Health Care Stocks Moving In Wednesday's Intraday SessionGainers NexImmune (NASDAQ:NEXI) shares moved upwards by 230.5% to $7.85 during Wednesday's regular session. The market value of their outstanding shares is at $8.3 million. ABVC BioPharma (NASDAQ:ABVC) stock increased by 58.36% to $1.9. The market value of their outstanding shares is at $14.7 million. First Wave BioPharma (NASDAQ:FWBI) shares rose 33.76% to $5.11. The market value of their outstanding shares is at $3.4 million. Dyne Therapeutics (NASDAQ:DYN) stock moved upwards by 24.06% to $16.2. The company's market cap stands at $994.4 million. Voyager Therapeutics (NASDAQ:VYGR) shares moved upwards by 21.55% to $10.94. The company's market cap stands at $481.3 million. Elicio Thera
- NEWSCrude Oil Gains Over 3%; US Manufacturing Activity Contracts For 14th Consecutive MonthU.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 150 points on Wednesday. The Dow traded down 0.79% to 37,417.28 while the NASDAQ fell 1.01% to 14,616.58. The S&P 500 also fell, dropping, 0.78% to 4,705.94. Check This Out: How To Earn $500 A Month From Apple Stock Following Tuesday's Slide Leading and Lagging Sectors Energy shares rose by 0.6% on Wednesday. In trading on Wednesday, real estate shares fell by 2.2%. Top Headline The ISM Manufacturing PMI rose to 47.4 in December from 46.7 in the prior month, and topping than market estimates of 47.1. However, the recent reading signalled contraction in factory activity for the 14th
NMRD FAQ
7 questionsWhat does Nemaura Medical Inc. do?
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company was founded in 2009 and is based in New York, New York.What is the latest news on NMRD?
Quantisnow has not tracked any new filings, ratings or press releases for NMRD in the last 30 days. The most recent wire item was published on September 26, 2024.Where does NMRD stock trade?
Nemaura Medical Inc. (NMRD) is listed on NASDAQ.What sector and industry is NMRD in?
Nemaura Medical Inc. operates in the Health Care sector, Medical/Dental Instruments industry.What are analysts saying about NMRD?
Nemaura Medical Inc. has had 2 recent analyst actions on file. The most recent action was from H.C. Wainwright: Buy with a $12.00 price target on 2022-03-29. Recent price targets range from $7.50 to $12.00.What companies are similar to NMRD?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare NMRD side-by-side with any of them on Quantisnow.How can I track NMRD on Quantisnow?
Quantisnow aggregates Nemaura Medical Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NMRD to receive live email and push alerts on every new disclosure.